On Wednesday, Vigil Neuroscience announced that the IGNITE phase 2 trial in ALSP patients has been discontinued.

Find out more and read their letter to the ALSP community: alextlc.org/.../vigil-ne...

#alextlc #helptocope #helptohope #leukodystrophy #alsp #hdls #csf1r